Rapport Therapeutics (RAPP) Revenue & Revenue Breakdown
Rapport Therapeutics Revenue Highlights
00
Rapport Therapeutics Revenue by Period
Rapport Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | - |
Rapport Therapeutics generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Rapport Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | - | -100.00% |
| 2026-03-31 | $20.00M | 100.00% |
| 2025-12-31 | - | 100.00% |
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | - |
Rapport Therapeutics generated - in revenue during Q2 2026, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Rapport Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ANAB | AnaptysBio | $234.60M | $25.56M |
| PHAT | Phathom Pharmaceuticals | $175.11M | $74.27M |
| URGN | UroGen Pharma | $109.79M | $72.46M |
| NRIX | Nurix Therapeutics | $83.98M | $9.04M |
| SEPN | Septerna | $45.95M | $26.75M |
| OCS | Oculis | $883.00K | - |
| KOD | Kodiak Sciences | - | - |
| RAPP | Rapport Therapeutics | - | - |
| BBOT | BridgeBio Oncology Therapeutics | - | - |
| XNCR | Xencor | - | - |
| MNMD | Mind Medicine (MindMed) | - | - |